35120-34-4 Usage
Description
(S)-1-ethyl-2-hydroxymethylpyrrolidine, with the molecular formula C7H15NO, is a chiral chemical compound featuring a pyrrolidine ring with an ethyl and hydroxymethyl group attached. (S)-1-ethyl-2-hydroxymethylpyrrolidine is significant in the field of asymmetric synthesis, where it serves as a chiral ligand, and is also recognized for its potential pharmacological properties.
Uses
Used in Pharmaceutical and Agrochemical Industries:
(S)-1-ethyl-2-hydroxymethylpyrrolidine is used as a chiral ligand in asymmetric synthesis for the production of pharmaceuticals and agrochemicals. Its ability to facilitate asymmetric reactions is crucial in creating enantiomerically pure compounds, which are essential for the development of effective and safe drugs and agrochemicals.
Used in Organic Synthesis:
(S)-1-ethyl-2-hydroxymethylpyrrolidine is used as an important building block in organic synthesis. The presence of the pyrrolidine ring and the attached functional groups make it a versatile compound for constructing a wide range of organic molecules.
Used in Research and Development:
(S)-1-ethyl-2-hydroxymethylpyrrolidine is also utilized in research and development for investigating its potential role in the treatment of certain diseases. Its pharmacological properties are of interest to scientists seeking novel therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 35120-34-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,5,1,2 and 0 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 35120-34:
(7*3)+(6*5)+(5*1)+(4*2)+(3*0)+(2*3)+(1*4)=74
74 % 10 = 4
So 35120-34-4 is a valid CAS Registry Number.
35120-34-4Relevant articles and documents
RAS INHIBITORS AND METHODS OF USING THE SAME
-
Paragraph 000150, (2021/08/06)
Provided herein are compounds identified as inhibitors of KRAS protein activity that can be used to treat various diseases and disorders, such as cancer.
A Convenient Reduction of Amino Acids and Their Derivatives
McKennon, Marc J.,Meyers, A. I.,Drauz, Karlheinz,Schwarm, Michael
, p. 3568 - 3571 (2007/10/02)
-
